Powered by

-BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(4)

Aug 06, 2019 - ENP Newswire

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst's board of directors granted six newly-hired employees options to purchase an aggregate of 42,000 shares of BioCryst common stock on July 31, 2019 as inducements material to each employee entering into employment with BioCryst.

The options were granted in accordance with NASDAQ Listing Rule 5635(4).

The options have an exercise price of $ 3.17 per share, which is equal to the clo...